GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $851,800,000 | +3.1% | 19,568,124 | +3.2% | 0.60% | +23.8% |
| Q1 2022 | $826,212,000 | +2.8% | 18,967,209 | +4.1% | 0.49% | +8.2% |
| Q4 2021 | $803,377,000 | +17.9% | 18,217,167 | +2.2% | 0.45% | +6.4% |
| Q3 2021 | $681,300,000 | -2.5% | 17,830,400 | +1.6% | 0.42% | -3.6% |
| Q2 2021 | $698,761,000 | +15.0% | 17,547,991 | +3.1% | 0.44% | +2.6% |
| Q1 2021 | $607,515,000 | -0.1% | 17,021,985 | +3.0% | 0.43% | -6.1% |
| Q4 2020 | $608,179,000 | -0.4% | 16,526,594 | +1.9% | 0.46% | -14.8% |
| Q3 2020 | $610,755,000 | -5.7% | 16,226,217 | +2.2% | 0.54% | -15.3% |
| Q2 2020 | $647,671,000 | +10.0% | 15,878,173 | +2.2% | 0.63% | -13.4% |
| Q1 2020 | $588,809,000 | -18.7% | 15,539,965 | +0.8% | 0.73% | -0.3% |
| Q4 2019 | $724,255,000 | +11.1% | 15,412,961 | +1.0% | 0.73% | +2.4% |
| Q3 2019 | $651,621,000 | +17.5% | 15,267,588 | +10.2% | 0.72% | +16.6% |
| Q2 2019 | $554,486,000 | -51.7% | 13,855,220 | -51.7% | 0.61% | -15.3% |
| Q1 2019 | $1,147,990,000 | +113.0% | 28,678,563 | +103.4% | 0.72% | -1.6% |
| Q4 2018 | $538,859,000 | -4.3% | 14,102,560 | +0.7% | 0.74% | +7.8% |
| Q3 2018 | $562,835,000 | +1.0% | 14,011,328 | +1.4% | 0.68% | -5.5% |
| Q2 2018 | $557,250,000 | +6.2% | 13,824,123 | +2.9% | 0.72% | +3.9% |
| Q1 2018 | $524,645,000 | +15.7% | 13,428,344 | +5.1% | 0.70% | +17.6% |
| Q4 2017 | $453,297,000 | -13.0% | 12,779,721 | -0.4% | 0.59% | -19.0% |
| Q3 2017 | $520,827,000 | -3.6% | 12,828,251 | +2.3% | 0.73% | -10.3% |
| Q2 2017 | $540,483,000 | +7.1% | 12,534,385 | +4.7% | 0.82% | +0.9% |
| Q1 2017 | $504,650,000 | +11.0% | 11,969,866 | +1.4% | 0.81% | +2.0% |
| Q4 2016 | $454,784,000 | -11.1% | 11,809,500 | -0.4% | 0.79% | -12.8% |
| Q3 2016 | $511,572,000 | +0.2% | 11,861,172 | +1.1% | 0.91% | -4.1% |
| Q2 2016 | $510,528,000 | +2.1% | 11,730,875 | +0.6% | 0.95% | -0.3% |
| Q1 2016 | $499,889,000 | +7.4% | 11,657,855 | +1.1% | 0.95% | +6.0% |
| Q4 2015 | $465,303,000 | +5.0% | 11,531,673 | +0.0% | 0.90% | -2.9% |
| Q3 2015 | $443,254,000 | -7.7% | 11,528,069 | -0.0% | 0.92% | -1.2% |
| Q2 2015 | $480,365,000 | -3.2% | 11,533,371 | +7.2% | 0.93% | -5.8% |
| Q1 2015 | $496,439,000 | +7.9% | 10,757,080 | -0.1% | 0.99% | +4.3% |
| Q4 2014 | $460,096,000 | -12.9% | 10,765,004 | -6.3% | 0.95% | -15.5% |
| Q3 2014 | $528,131,000 | -13.1% | 11,488,594 | +1.1% | 1.13% | -11.9% |
| Q2 2014 | $607,849,000 | +1.4% | 11,365,903 | +1.4% | 1.28% | -5.4% |
| Q1 2014 | $599,184,000 | +1.0% | 11,214,364 | +0.9% | 1.35% | +0.5% |
| Q4 2013 | $593,211,000 | +6.3% | 11,110,909 | -0.1% | 1.34% | -2.3% |
| Q3 2013 | $557,844,000 | +0.1% | 11,119,081 | -0.3% | 1.38% | -4.9% |
| Q2 2013 | $557,079,000 | – | 11,148,275 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |